ITN Contributing Editor Greg Freiherr speaks with Guerbet Chief Commercial Officer David Hale about the latest advanced ...
January 21, 2019 – Medical experts have released “Guidelines for Performing a Comprehensive Transthoracic ...
Hologic announced that the U.S. Food and Drug Administration (FDA) has cleared the LOCalizer radiofrequency identification (RFID) marker for long-term placement. With this clearance, the marker can now be implanted more than 30 days prior to a breast-conserving surgery, providing even greater flexibility and convenience to patients and providers.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
The cost of unnecessary repeat imaging can be significant, both on the patient and organization. With the help of a ...
The U.S. Food and Drug Administration (FDA) has cleared the Multix Impact, an affordably priced, floor-mounted digital radiography (DR) system from Siemens Healthineers that expands access to high-quality imaging and enhances the patient experience.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus a ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Visage Imaging Inc. announced the signing of Partners HealthCare, the largest health system in Massachusetts, for implementation of the Visage 7 Enterprise Imaging Platform. Visage will be exhibiting at the 2019 Healthcare Information and Management Systems Society annual meeting (HIMSS19), Feb. 12-14 in Orlando, Fla.
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology
Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided procedures.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s IntelliSpace Enterprise Edition solution across its hospitals and facilities. In a 10-year agreement, IntelliSpace Enterprise Edition will provide the health system with access to Philips’ full suite of informatics solutions across radiology, cardiology and analytics to help improve efficiencies and care delivery.
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study appearing in the journal Radiology.
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy (MRT) dosimetry.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer, according to a new study published in the journal Radiology. The researchers said the study, the result of a collaboration between breast imagers and AI experts, represents a groundbreaking implementation of AI into routine clinical practice.
In Artificial Intelligence 2018: What Radiologists Need to Know About AI, ITN Contributing Editor Greg Freiherr offers ...
In Enterprise Imaging 2018: Balancing Strategy and Technology in Enterprise Imaging, ITN Contributing Editor Greg ...
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully employed machine learning to uncover new insights into the cellular architecture of the human brain.
Julius Chapiro, M.D., research faculty member and an interventional radiology resident at Yale University, describes how ...
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced clinical confidence for radiologists. ABUS can play an important role in early diagnosis of small, node negative, invasive cancers. https://www.itnonline.com/content/ge-healthcare-introduces-invenia-abus…
January 10, 2019 — A research team led by investigators from the National Institutes of Health and Global Good has ...
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study timeframes and create more comprehensive sample sizes, according to research published in Survey Practice.